FDA warns drug company in India
Tuesday, September 16, 2008 - 14:30
in Mathematics & Economics
WASHINGTON, Sept. 16 (UPI) -- The U.S. Food and Drug Administration has issued warning letters and an import alert for generic drugs produced by Ranbaxy Laboratories Ltd. of India.